Oncocross Co., Ltd. (382150.KQ) Financial Statements

Income statement

Metric	TTM	2025	2024	2023	2022
Revenue
Total Revenue	395.5M	370.5M	1.1B	91.5M	150.2M
Cost of Revenue	1.6B	—	350.1M	87.0M	115.6M
Gross Profit	(1.2B)	370.5M	722.1M	4.5M	34.6M
Operating Expenses
R&D Expense	3.1B	3.3B	2.6B	2.9B	5.9B
SG&A Expense	2.9B	1.3B	907.4M	868.9M	3.6B
General & Admin Expense	163.9M	230.8M	218.8M	166.1M	138.9M
Selling & Marketing Expense	896.2M	1.1B	688.6M	702.8M	896.9M
Other Expenses	3.1B	4.6B	4.2B	3.1B	471.5M
Total Operating Expenses	8.3B	9.2B	7.7B	6.8B	10.0B
Cost and Expenses	10.2B	9.2B	8.0B	6.9B	10.1B
Operating Income (EBIT)	(9.8B)	(8.8B)	(7.0B)	(6.8B)	(10.0B)
Non-Operating
Interest Income	641.0M	389.4M	324.6M	125.4M	101.6M
Interest Expense	1.3B	526.3M	18.8M	38.3M	76.5M
Net Interest Income	(682.6M)	(136.8M)	305.8M	87.1M	25.1M
Other Non-Op Income/Expense	3.2B	(98.2M)	481.7M	2.7B	(204.8M)
Non-Operating Income (excl Interest)	(410.7M)	(428.1M)	(500.4M)	(2.7B)	128.3M
EBT (Pre-Tax Income)	(6.5B)	(8.9B)	(6.5B)	(4.1B)	(10.2B)
Income Tax Expense	—	—	—	108.3M	—
Bottom Line
Net Income	(6.5B)	(8.9B)	(6.5B)	(4.2B)	(10.2B)
Earnings from Cont. Ops	(6.5B)	(8.9B)	(6.5B)	(4.2B)	(10.2B)
Earnings from Discont. Ops	—	—	—	—	—
Bottom Line Net Income	(10.1B)	(8.9B)	(6.5B)	(4.2B)	(10.2B)
Per Share
Basic EPS	(₩543)	(₩747)	(₩619)	(₩473)	(₩1,162)
Diluted EPS	(₩805)	(₩747)	(₩619)	(₩473)	(₩1,162)
Revenue Per Share	₩32	₩31	₩102	₩10	₩17
Shares
Basic Shares Outstanding	12.2M	12.0M	10.5M	8.9M	8.8M
Diluted Shares Outstanding	14.3M	12.0M	10.5M	8.9M	8.8M
Profitability Metrics
EBITDA	(10.5B)	(8.0B)	(6.1B)	(3.6B)	(9.8B)
D&A	1.1B	812.3M	406.7M	438.4M	369.1M
EBIT	(9.0B)	(8.8B)	(6.5B)	(4.1B)	(10.1B)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026